ERIC DOBMEIER - 23 Jun 2022 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role: Director
Signature: /s/ David Tucker, Attorney-in-Fact
Issuer symbol: ATRA
Transactions as of: 23 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2022, 16:48:03 UTC
Previous filing: 27 May 2022
Next filing: 11 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ATRA	Common Stock	Award	$0	+20,500	+53%	$0.000000	59,500	23 Jun 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATRA	Non-Qualified Stock Option (Right to Buy)	Award	$0	+31,500		$0.000000	31,500	23 Jun 2022	Common Stock	31,500	$7.35	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
F2	The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.